Results: 4

Carnitine analysis in pterygium

Arq. bras. oftalmol; 83 (1), 2020
ABSTRACT Purpose: The aim of the present study was to measure the free carnitine and acylcarnitine levels in pterygium tissue and normal conjunctival tissue at the metabolomics level using tandem mass spectrometry. Methods: In this prospective, clinical randomized study, pterygium tissues and normal co...

Expression of specificity protein 1 and collagen I in primary pterygial tissues

Arq. bras. oftalmol; 82 (5), 2019
ABSTRACT Purpose: To determine the expression profiles of the transcription factor specificity protein 1 and collagen I in primary pterygial and normal conjunctival tissues, and to explore the role of specificity protein 1 and collagen I in pterygial development. Methods: The pterygial tissues of 20 pa...

Topical cyclosporine A 0. 05% before and after surgery to prevent pterygium recurrence

Arq. bras. oftalmol; 82 (5), 2019
ABSTRACT Purpose: We evaluated the role of the conjunctival flap rotation technique using 5-fluorouracil and adjuvant therapy with topical cyclosporine A at 0.05% during short pre- and postoperative periods for the prevention of primary pterygium recurrence. Methods: In this prospective study, 76 patie...

Ocular findings in Fabry disease in Colombian patients

Biomédica (Bogotá); 39 (3), 2019
ABSTRACT Fabry disease is a rare X-linked disorder caused by an alpha-galactosidase enzyme deficiency, which leads to a progressive lysosomal glycosphingolipids accumulation, mainly globotriaosylceramide, in multiple organism tissues including the eye. This case series describes the first ophthalmologica...